The result demonstrated that shallow deletions in ASPM (P = 0.0170, Figure 8D), CENPA (P = 0.0071, Figure 8H), EXO1 (P = 0.0069, Figure 8I), HJURP (P = 0.0200, Figure 8K), and NUF2 (P = 0.0450, Figure 8N) led to better OS of patients with ACC compared with those being affected by copy number gains, while patients with shallow deletions in AURKA (P = 0.0150, Figure 8E), MKI67 (P = 0.0039, Figure 8M), PARPBP (P < 0.0001, Figure 8O), and TACC3 (P = 0.0016, Figure 8P) had poorer OS. This evidence concerns the gene EXO1 and adrenal cortex carcinoma.